Miyuki Sato

Niigata, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 13 publications

High FDG Uptake in the Non-cancerous Lung Predicts Immune-Related Adverse Events and Poor Prognosis in Patients with Lung Cancer Treated with Immune Checkpoint Inhibitors.

High FDG Uptake in the Non-cancerous Lung Predicts Immune-Related Adverse Events and Poor Prognosis in Patients with Lung Cancer Treated with Immune Checkpoint Inhibitors.

Journal: Academic radiology

Published: February 09, 2026

Muscle loss and pentraxin-3 as predictors of immunotherapy outcomes in non-small cell lung cancer: a prospective study.

Muscle loss and pentraxin-3 as predictors of immunotherapy outcomes in non-small cell lung cancer: a prospective study.

Journal: Scientific reports

Published: January 04, 2026

Sarcomatoid Transformation of Pulmonary Mucinous Adenocarcinoma as a Mechanism of Immunotherapy Resistance.

Sarcomatoid Transformation of Pulmonary Mucinous Adenocarcinoma as a Mechanism of Immunotherapy Resistance.

Journal: Thoracic cancer

Published: December 27, 2025

Nintedanib enhances the antitumor efficacy of pd-1 blockade, potentially through inhibition of myeloid-derived suppressor cells and cancer-associated fibroblasts.

Nintedanib enhances the antitumor efficacy of pd-1 blockade, potentially through inhibition of myeloid-derived suppressor cells and cancer-associated fibroblasts.

Journal: Cancer immunology, immunotherapy : CII

Published: November 24, 2025

Successful treatment with tepotinib followed by pembrolizumab in pulmonary pleomorphic carcinoma harbouring a MET exon 14 skipping mutation: A case report.

Successful treatment with tepotinib followed by pembrolizumab in pulmonary pleomorphic carcinoma harbouring a MET exon 14 skipping mutation: A case report.

Journal: Oncology letters

Published: September 25, 2025

Anti-cancer therapy and the exacerbation of pulmonary nontuberculous mycobacterial infection.

Anti-cancer therapy and the exacerbation of pulmonary nontuberculous mycobacterial infection.

Journal: Respiratory investigation

Published: May 23, 2025

Risk of lung injury with immune checkpoint inhibitors after talc pleurodesis: A retrospective study.

Risk of lung injury with immune checkpoint inhibitors after talc pleurodesis: A retrospective study.

Journal: Lung cancer (Amsterdam, Netherlands)

Published: April 02, 2025

The diagnostic value of comprehensive next-generation sequencing for genetic mutations in suspected lung cancer cases with negative pathological cytology.

The diagnostic value of comprehensive next-generation sequencing for genetic mutations in suspected lung cancer cases with negative pathological cytology.

Journal: Lung cancer (Amsterdam, Netherlands)

Published: January 26, 2025

PD-1 blockade therapy augments the antitumor effects of lymphodepletion and adoptive T cell transfer.

PD-1 blockade therapy augments the antitumor effects of lymphodepletion and adoptive T cell transfer.

Journal: Cancer immunology, immunotherapy : CII

Published: March 20, 2021

Combination therapy of cisplatin with cilastatin enables an increased dose of cisplatin, enhancing its antitumor effect by suppression of nephrotoxicity.

Combination therapy of cisplatin with cilastatin enables an increased dose of cisplatin, enhancing its antitumor effect by suppression of nephrotoxicity.

Journal: Scientific reports

Published: May 02, 2020

Retrospective analysis of antitumor effects and biomarkers for nivolumab in NSCLC patients with EGFR mutations.

Retrospective analysis of antitumor effects and biomarkers for nivolumab in NSCLC patients with EGFR mutations.

Journal: PloS one

Published: September 05, 2018

A Case of Drug-Induced Organizing Pneumonia Caused by Dasatinib

A Case of Drug-Induced Organizing Pneumonia Caused by Dasatinib

Journal: Gan to kagaku ryoho. Cancer & chemotherapy

Published: July 21, 2018

Showing 1-12 of 13

Last Updated: 09/26/2026